Amended and Restated Employment Agreement - Charles A. Rowland, Jr.



 Exhibit 10.26 
 AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT
(this “Agreement”) is made as of December 31, 2006 by Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Employer”), and Charles A. Rowland, Jr. (the “Employee”). 
 WHEREAS, the Employee has been employed by the Employer pursuant to the terms of an Employment Agreement, dated as of December 6, 2006 (the
“Original Agreement”); and 
 WHEREAS, the Employer and the Employee each desire to amend and restate the Original Agreement in its
entirety; 
 NEW THEREFORE, intending to be legally bound, and in consideration of the mutual agreements contained herein, the parties agree
to amend and restate the Original Agreement in its entirety as follows: 
 ARTICLE 1. DEFINITIONS. 
 For the purposes of this Agreement, the following terms have the meanings specified or referred to in this Article 1. 
 “Agreement” means this Employment Agreement, including the Exhibits hereto, as amended from time to time. 
 “Basic Compensation” means Salary and Benefits. 
 “Benefits” shall have the meaning set forth in Section 3.1(b). 
 “Board of
Directors” means the board of directors of the Employer. 
 “Confidential Information” means any and all:

 (a) trade secrets concerning the business and affairs of the Employer, product specifications, data, know-how, formulae, compositions,
processes, designs, sketches, photographs, graphs, drawings, samples, inventions and ideas, past, current, and planned research and development, current and planned manufacturing or distribution methods and processes, customer lists, current and
anticipated customer requirements, price lists, market studies, business plans, computer software and programs (including object code and source code), computer software and database technologies, systems, structures, and architectures (and related
formulae, compositions, processes, improvements, devices, know-how, inventions, discoveries, concepts, ideas, designs, methods and information); 
 (b) information concerning the business and affairs of the Employer (which includes unpublished financial statements, financial projections and budgets, unpublished and 

  

 -1- 








 
projected sales, capital spending budgets and plans, the names and backgrounds of key personnel, to the extent not publicly known, personnel training and
techniques and materials) however documented; and 
 (c) notes, analysis, compilations, studies, summaries, and other material prepared by or
for the Employer containing or based, in whole or in part, on any information included in the foregoing. 
 “disability”
shall have the meaning set forth in Section 6.2. 
 “Effective Date” means January 1, 2007. 
 “Employment Period” shall have the meaning set forth in Section 2.2. 
 “Fiscal Year” means the Employer’s fiscal year, as it exists on the Effective Date or as changed from time to time. 
 “for cause” shall have the meaning set forth in Section 6.3. 
 “for good reason” shall have the meaning set forth in Section 6.4. 
 “Incentive Compensation” shall have the meaning set forth in Section 3.2. 
 “person” means any individual, corporation (including any non-profit corporation), general or limited partnership, limited liability
company, joint venture, estate, trust, association, organization, or governmental body. 
 “Post-Employment Period” shall
have the meaning set forth in Article 8. 
 “Renewal Term” shall have the meaning set forth in Section 2.2. 

“Salary” shall have the meaning set forth in Section 3.1(a). 
  

 -2- 








 ARTICLE 2. EMPLOYMENT TERMS AND DUTIES. 
 Section 2.1 Employment. The Employer hereby employs the Employee, and the Employee hereby accepts employment by the Employer, upon the
terms and conditions set forth in this Agreement. 
 Section 2.2 Term. Subject to the provisions of Article 6, the term of
the Employee’s employment under this Agreement will be a rolling twenty-four month period commencing each day after the Effective Date and ending on the twenty-four month anniversary of such day (the “Employment Period”). For purposes
of this Agreement, employment and compensation paid by any direct or indirect subsidiary of the Employer will be deemed to be employment and compensation paid by the Employer. 
 Section 2.3 Duties. The Employee will have such duties as are described on Exhibit A attached hereto and made a part hereof and such
similar duties as are assigned or delegated to the Employee by the Chief Executive Officer, and will serve as Executive Vice President, Chief Financial Officer and Treasurer of the Employer. The Employee will devote the Employee’s business,
time, attention, skill, and energy to the business of the Employer, will promote the success of the Employer’s business, and will cooperate with the Chief Executive Officer and the Board of Directors in the advancement of the best interests of
the Employer. Nothing in this Section 2.3, however, will prevent the Employee from engaging in additional activities in connection with personal investments, corporate directorships and community affairs that are not inconsistent with the
Employee’s duties under this Agreement. It is expressly understood and agreed that to the extent any such activities have been conducted by the Employee prior to the Effective Date, the continued conduct of such activities (or the conduct of
activities similar in nature and scope thereto) subsequent to the Effective Date shall not thereafter be deemed to be inconsistent with the Employee’s duties under this Agreement. The Employee shall, from time to time, inform the Chief
Executive Officer of those additional activities in which the Employee is engaged. If, at any time, the Employee is elected as a director of the Employer or as a director or officer of any of Employer’s subsidiaries, the Employee will fulfill
the Employee’s duties as such director or officer without additional compensation. 
 Section 2.4 Director’s and
Officer’s Liability Coverage. The Employer shall cause the Employee to be (a) indemnified as an officer and/or director of the Employer or any of its affiliates, to the extent applicable, to the maximum extent permitted by
applicable law, and (b) covered by director’s and officer’s liability insurance in connection with the Employee serving as an officer and/or director of Employer or any of its affiliates. The provisions of this Section 2.4 shall
survive termination of this Agreement for any reason. 
 ARTICLE 3. COMPENSATION. 
 Section 3.1 Basic Compensation. 
 (a) Salary. The Employee will be paid an annual salary of $450,000, subject to adjustment as provided below (the “Salary”), which will be payable in equal periodic 

  

 -3- 








 
installments according to the Employer’s customary payroll practices, but no less frequently than the 15th and the last day of each month. The Salary, upon a recommendation by the Chief Executive Officer, will be reviewed by the Compensation Committee of the Board
of Directors (the “Committee”) not less frequently than annually, and be adjusted in the sole discretion of the Committee, but in no event will the Salary be less than $450,000 per year. In determining the amount of any adjustment to
Salary, the Committee shall take into account inflation, merit, changes in responsibilities and industry salary practices for executives. Any increase in Salary shall not serve to limit or reduce any other obligation to the Employee under this
Agreement. Salary shall not be reduced after such increase unless such reduction is part of a reduction in salaries of specified management personnel of the Employer undertaken in a program approved by the Employer’s Board of Directors.

 (b) Benefits. The Employee will, during the Employment Period, be permitted to participate in such incentive, savings,
pension, profit sharing, bonus, life insurance, hospitalization and major medical, and other employee benefit plans, practices, policies and programs, of the Employer that may be in effect from time to time, to the extent the Employee is eligible
under the terms of those plans (collectively, the “Benefits”). 
 (c) Stock Options/Restricted Shares. To the extent
the Employer determines to award stock options, restricted shares or other similar consideration to management personnel based upon duration of employment or achieving performance targets, or both, the Employee shall be permitted to participate in
such programs. For each Fiscal Year or part thereof during the Employment Period the Employee shall be eligible to earn as additional compensation for the services to be rendered by the Employee pursuant to this Agreement, long-term equity
incentives in an amount equal up to one hundred fifty percent (150%) of the Salary for such Fiscal Year (or such lesser (including zero) or greater percent of the Salary for such Fiscal Year as is recommended in good faith to the Committee by
the Chief Executive Officer of the Employer and approved by the Committee). On the December 6, 2006 (the Employee’s first day of employment with the Employer), the Employee was granted (i) 100,000 stock options under the 2004 Stock
Incentive Plan and (ii) in lieu of a 2007 option grant, additional stock options under the 2004 Stock Incentive Plan valued at $250,000, with all such options valued with reference to the closing market price on the December 6, 2006.

 Section 3.2 Incentive Compensation. For each Fiscal Year or part thereof during the Employment Period the Employee
shall be eligible to be paid in cash additional compensation (the “Incentive Compensation”) for the services to be rendered by the Employee pursuant to this Agreement, an amount equal to fifty percent (50%) of the Salary for such
Fiscal Year (or such lesser (including zero) or greater (not to exceed two hundred) percent of the Salary for such Fiscal Year as is recommended in good faith to the Committee by the Chief Executive Officer of the Employer and approved by the
Committee) if the Employer achieves certain performance targets set by the Committee (the “Performance Targets”) for such Fiscal Year; it being understood that the Employee shall receive full year 2006 Incentive Compensation in an
amount equal to 50% of the Salary. Incentive Compensation for each Fiscal Year or part thereof shall be paid as soon as practicable following the receipt by the Employer of its audited financial statements for the Fiscal Year for which the Incentive
Compensation is being paid, unless the 

  

 -4- 








 
Employee shall elect to defer the receipt of such Incentive Compensation. The Employee shall be permitted to submit a proposal for additional incentive
compensation with respect to the period commencing on the date hereof and ending at the end of the Employers’ current Fiscal Year, and the Employer shall consider such proposal in good faith. 
 Section 3.3 Relocation. The Employer will provide the Employee with a relocation allowance of up to $75,000 to cover documented and
reasonable moving expenses that are incurred within twelve (12) months of the Effective Date, and an additional sum of $75,000 to cover any realtor’s fees incurred by the Employee in connection with his relocation to the Chadds Ford, PA
area shall be paid by the Employer. The Employee shall also be eligible for temporary living expense reimbursement, to be pre-approved by Employer, for up to twelve (12) months after the Effective Date. All such sums must be repaid to the
Employer in the event the Employee voluntarily terminates his employment within eighteen (18) months of the Effective Date. 
 ARTICLE 4.
FACILITIES AND EXPENSES. 
 Section 4.1 Reimbursement. The Employer will furnish the Employee office space,
equipment, supplies, and such other facilities and personnel as the Employer deems necessary or appropriate for the performance of the Employee’s duties under this Agreement. The Employer will pay the Employee’s dues in such professional
societies and organizations as are appropriate, and will pay on behalf of the Employee (or reimburse the Employee for) reasonable expenses incurred by the Employee at the request of, or on behalf of, the Employer in the performance of the
Employee’s duties pursuant to this Agreement, and in accordance with the Employer’s employment policies, including reasonable expenses incurred by the Employee in attending conventions, seminars, and other business meetings and in
appropriate business entertainment activities. The Employee must file expense reports with respect to such expenses in accordance with the Employer’s policies. 
 Section 4.2 Motor Vehicle Allowance. As of the Effective Date, the Employee will be entitled to use of an automobile, and a replacement thereof, mutually acceptable to the Employee and the Employer,
at least every three (3) fiscal years after the Effective Date during the Employment Term. The Employer will reimburse the Employee for all operating expenses relating thereto upon the Employee’s submission of appropriate documentation as
set forth in Section 4.1. The Employer will determine the actual value, if any, of the Employee’s non-business use of such automobile and will furnish the Employee with a W-2 Wage and Tax Statement, grossed up for taxes, to be included in
the Employee’s income tax returns, in accordance with prevailing Internal Revenue Service regulations. 
 ARTICLE 5. VACATIONS AND HOLIDAYS.

 The Employee will be entitled to paid vacation each Fiscal Year in accordance with the vacation policies of the Employer in effect for
its executive officers from time to time, provided that in no event shall such number of paid vacation days be fewer than twenty. Vacation must be taken by the Employee at such time or times as approved by the Chief 

  

 -5- 








 
Executive Officer. The Employee will also be entitled to the paid holidays and other paid leave set forth in the Employer’s policies. Vacation days and
holidays during any Fiscal Year that are not used by the Employee during such Fiscal Year may be used in any subsequent Fiscal Year. 
 ARTICLE 6.
TERMINATION AND ELECTION NOT TO RENEW. 
 Section 6.1 Events of Termination. The Employment Period, the
Employee’s Basic Compensation and Incentive Compensation, and any and all other rights of the Employee under this Agreement or otherwise as an employee of the Employer will terminate (except as otherwise provided in this Article 6): 

(a) upon the death of the Employee; 
 (b) upon the disability of the Employee (as defined in Section 6.2); 
 (c) for cause (as defined in
Section 6.3), immediately upon notice from the Employer to the Employee, or at such later time as such notice may specify, unless otherwise provided in Section 6.3; 
 (d) without cause upon not less than thirty days’ prior notice from the Employer to the Employee; 
 (e) for good reason (as defined in Section 6.4) upon not less than thirty days’ prior notice from the Employee to the Employer; or

 (f) by the Company other than for cause upon not less than thirty days’ prior notice from the Employer to the Employee or by
the Employee for good reason, in each case within 12 months following the occurrence of a Change of Control (as defined in Section 6.5(e)). 
 Section 6.2 Definition of Disability. For purposes of Sections 6.1 and 6.3, the Employee will be deemed to have a “disability” if, as a result of the Employee’s incapacity due to reasonably documented
physical illness or injury or mental illness, the Employee shall have been unable for more than six months in any twelve month period to perform Employee’s duties hereunder on a full time basis and within 30 days after written notice of
termination has been give to the Employee, the Employee shall not have returned to the full time performance of such duties. The date of termination in the case of a termination for “disability” shall be the last day of the aforementioned
30-day period. 
 Section 6.3 Definition of “For Cause.” For purposes of Section 6.1, the phrase “for
cause” means: (a) the continued failure, for a period of thirty (30) days after written demand is delivered to the Employee which specifically identifies the failure, by the Employee substantially to perform the Employee’s duties
under this Agreement (other than any such failure resulting from “disability”), (b) the Employee makes, or is found to have made, a false certification relating to Endo Pharmaceuticals Holdings Inc.’s financial
statements, (c) the criminal felony indictment of the Employee by a court of competent jurisdiction, (d) the 
  

 -6- 








 
engagement by the Employee in serious misconduct that has caused, or in the good faith judgment of the Board of Directors may cause if not discontinued,
material harm (financial or otherwise) to the Employer or any of its subsidiaries, if any (provided that with respect to misconduct that the Board of Directors determines may cause material harm if not discontinued, a written demand is delivered to
the Employee specifically identifying the misconduct and the Employee continues the misconduct), such material harm to include, without limitation, (i) the disclosure of material secret or Confidential Information of the Employer or any of its
subsidiaries, if any, (ii) the debarment of the Employer or any of its subsidiaries, if any, by the U.S. Food and Drug Administration or any successor agency (the “FDA”), or (iii) the registration of the Employer or any of its
subsidiaries, if any, with the U.S. Drug Enforcement Administration of any successor agency (the “DEA”) to be revoked, (e) the debarment of the Employee by the FDA, or (f) the continued material breach by the Employee of this
Agreement after written demand is delivered to the Employee which specifically identifies the breach and failure to cure within thirty (30) days of such demand. 
 Section 6.4 Definition of “For Good Reason.” For purposes of Section 6.1, the phrase “for good reason” means any of the following: (a) The Employer’s material
breach Section 2.4, 3.1 or 3.2 or of this Agreement; or (b) the assignment of the Employee without the Employee’s consent to a position, responsibilities, or duties of a materially lesser status or degree of responsibility than the
Employee’s position, responsibilities, or duties at the Effective Date; or (c) the Employer requiring the Employee to be based at any office or location more than fifty (50) miles from the Employee’s current principal business
location. 
 Section 6.5 Termination Pay. Effective upon the termination of this Agreement, the Employer will be obligated
to pay the Employee (or, in the event of Employee’s death, Employee’s designated beneficiary as defined below) only such compensation as is provided in this Section 6.5. For purposes of this Section 6.5, the Employee’s
designated beneficiary will be such individual beneficiary or trust, located at such address, as the Employee may designate by notice to the Employer from time to time or, if the Employee fails to give notice to the Employer of such a beneficiary,
the Employee’s estate. Notwithstanding the preceding sentence, the Employer will have no duty, in any circumstances, to attempt to open an estate on behalf of the Employee, to determine whether any beneficiary designated by the Employee is
alive or to ascertain the address of any such beneficiary, to determine the existence of any trust, to determine whether any person or entity purporting to act as the Employee’s personal representative (or the trustee of a trust established by
the Employee) is duly authorized to act in that capacity, or to locate or attempt to locate any beneficiary, personal representative, or trustee. 
 (a) Termination by the Employee for Good Reason or by the Employer Without Cause. If the Employee terminates this Agreement for good reason (except as otherwise provided in Section 6.5(e)) or if the Employer terminates
the Employee without cause, the Employer will (i) pay (A) monthly to the Employee the Employee’s Salary for twenty-four (24) months, and (B) a lump sum equal to two times the Employee’s target Incentive Compensation for
the Fiscal Year during which the termination is effective, and (ii) continue to provide the Employee with the Benefits for twenty-four (24) months. 
  

 -7- 








 (b) Termination by the Employer for Cause. If the Employer terminates this Agreement for
cause, the Employee will be entitled to receive the Employee’s Salary and Incentive Compensation prorated through the date such termination is effective 
 (c) Termination upon Disability. If this Agreement is terminated by either party as a result of the Employee’s disability, as determined under Section 6.2, the Employer will pay the Employee
the Salary and Incentive Compensation (if the applicable Performance Targets are met) through the remainder of the calendar month during which such termination is effective and the period until disability insurance benefits commence
(“Disability Coverage Commencement”) under the disability insurance coverage furnished by the Employer to the Employee. From and after Disability Coverage Commencement and for twenty-four (24) consecutive months thereafter, the
Employer will make regular payments to the Employee in the amount by which the Salary exceeds the Employee’s disability insurance benefits. 
 (d) Termination upon Death. If this Agreement is terminated because of the Employee’s death, the Employee will be entitled to receive the Employee’s Salary through the end of the calendar month in which the
Employee’s death occurs, and Incentive Compensation (if the applicable Performance Targets are met) for the Fiscal Year during which the Employee’s death occurs, prorated through the date of the Employee’s death. 
 (e) Termination upon Change of Control. If (A) following the occurrence of a tender offer, stock purchase, other stock acquisition,
merger, consolidation, recapitalization, reverse split, sale or transfer of assets or other transaction, as a result of which any person, entity or group, other than an Affiliate of the Company prior to the occurrence of such event, as the case may
be, (i) becomes the beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the ordinary shares of the Company or representing more than 50% of the combined voting power with respect to the election
of directors, (ii) appoints a majority of the board of directors of the Company or (iii) obtains the ability to direct the operations or management of the Company (each of the above, a “Change of Control”) and (B) within
twelve (12) months of such Change in Control, the Employee is terminated by the Employer (other than for cause, death or disability) or by the Employee for good reason, then the Employee will be entitled to receive (x) any accrued but
unpaid Salary to the date on which the termination is effective plus (y) a lump sum payment equal to two times the sum of (1) the Employee’s then current Salary plus (2) the higher of (a) Employee’s target Incentive
Compensation for the Fiscal Year during which the termination is effective or (b) Employee’s Incentive Compensation for the Fiscal Year immediately preceding the year in which the termination is effective, and (z) Benefits for a
period equal to twenty-four (24) months after the date on which the termination is effective. 
 (f) Benefits. Unless
otherwise specifically provided herein or otherwise provided for in the Benefits, the Employee’s accrual of, or participation in plans providing for, the Benefits will cease at the effective date of the termination of this Agreement, and the
Employee will be entitled to accrued Benefits pursuant to such plans only as provided in such plans. 
  

 -8- 








 ARTICLE 7. NON-DISCLOSURE COVENANT. 
 Section 7.1 Acknowledgments by the Employee. The Employee acknowledges that (a) during the Employment Period and as a part of the
Employee’s employment, the Employee will be afforded access to Confidential Information; and (b) public disclosure of such Confidential Information could have an adverse effect on the Employer and its business. 
 Section 7.2 Agreements of the Employee. In consideration of the compensation and benefits to be paid or provided to the Employee by
the Employer under this Agreement, the Employee covenants as follows: 
 (a) During and following the Employment Period, the Employee
will hold in confidence the Confidential Information and will not disclose it to any person except with the specific prior written consent of the Employer, as otherwise may be required by law or legal process or except as otherwise expressly
permitted by the terms of this Agreement. 
 (b) If any information that the Employer deems to be a trade secret is found by a court
of competent jurisdiction not to be a trade secret for purposes of this Agreement, such information will, nevertheless, be considered Confidential Information for purposes of this Agreement. The Employee hereby waives any requirement that the
Employer submit proof of the economic value of any trade secret or post a bond or other security. 
 (c) None of the foregoing
obligations and restrictions applies to any part of the Confidential Information that the Employee demonstrates was or became generally available to the public other than as a result of a disclosure by the Employee. 
 (d) Upon termination of this Agreement by either party, or upon the request of the Employer during the Employment Period, the Employee will return
to the Employer all Confidential Information in the Employee’s possession or subject to the Employee’s control, and the Employee may not retain any copies, abstracts, sketches, or other physical embodiment of any of the Confidential
Information. 
 ARTICLE 8. NON-COMPETITION AND NON-INTERFERENCE. 
 The Employee covenants that the Employee will not, directly or indirectly during the Employment Period, except in the course of the Employee’s employment hereunder, and during the Post-Employment Period, directly
or indirectly manage, operate, control, or participate in the management, operation, or control of, be employed by, associated with, or in any manner connected with, lend the Employee’s name to, or render services or advice to, any third party
or any business whose products compete (including as described below) in whole or in part with the products of the Employer (disregarding any non-pain management products that were not products promoted by the Employer during the last three years).

  

 -9- 








 For purposes of this Article 8, any third party or any business whose products compete includes any
entity with which the Employer has had a product(s) licensing agreement during the Employment Period and any entity with which the Employer is at the time of termination actively negotiating, and eventually concludes within six (6) months of
the Employment Period, a commercial agreement. The term “Post-Employment Period” means the period beginning on the effective date of termination of the Employee’s employment hereunder and ending on the later to occur of
(i) twenty-four (24) months after the effective date of such termination or (ii) the date amounts payable to Employee under Section 6.5 (a), (c) and (e) are to have been paid in full pursuant to this Agreement (provided
that notwithstanding anything in this Agreement to the contrary, such amounts are being timely paid by the Employer). 
 If any covenant in
this Article 8 is held to be unreasonable, arbitrary, or against public policy, such covenant will be considered to be divisible with respect to scope, time, and geographic area, and such lesser scope, time, or geographic area, or all of them, as a
court of competent jurisdiction may determine to be reasonable, not arbitrary, and not against public policy, will be effective, binding, and enforceable against the Employee. 
 ARTICLE 9. GENERAL PROVISIONS. 
 Section 9.1 Injunctive Relief and Additional
Remedy. The Employee acknowledges that the injury that would be suffered by the Employer as a result of a breach of the provisions of this Agreement (including any provision of Articles 7 and 8) would be irreparable and that an award of
monetary damages to the Employer for such a breach would be an inadequate remedy. Consequently, the Employer will have the right, in addition to any other rights it may have, to obtain injunctive relief to restrain any breach or threatened breach or
otherwise to specifically enforce any provision of this Agreement, and the Employer will not be obligated to post bond or other security in seeking such relief. 
 Section 9.2 Essential and Independent Covenants. The covenants by the Employee in Articles 7 and 8 are essential elements of this Agreement, and without the Employee’s agreement to comply with such
covenants, the Employer would not have entered into this Agreement or employed or continued the employment of the Employee. The Employer and the Employee have independently consulted their respective counsel and have been advised in all respects
concerning the reasonableness and propriety of such covenants, with specific regard to the nature of the business conducted by the Employer. 
 If the Employee’s employment hereunder expires or is terminated, this Agreement will continue in full force and effect as is necessary or appropriate to enforce the covenants and agreements of the Employee in Articles 7 and 8.

 Section 9.3 Duty to Mitigate. The Employee shall not be required to mitigate damages or the amount of any payment required
under this Agreement, nor shall the payments due Employee hereunder be reduced or offset by reason of any payments Employee may receive from any other source. 
  

 -10- 








 Section 9.4 Representations and Warranties by the Employee. The Employee represents and
warrants to the Employer that the execution and delivery by the Employee of this Agreement do not, and the performance by the Employee of the Employee’s obligations hereunder will not, with or without the giving of notice or the passage of
time, or both: (a) violate any judgment, writ, injunction, or order of any court, arbitrator, or governmental agency applicable to the Employee; or (b) conflict with, result in the breach of any provisions of or the termination of, or
constitute a default under, any agreement to which the Employee is a party or by which the Employee is or may be bound. 
 Section 9.5
Waiver. The rights and remedies of the parties to this Agreement are cumulative and not alternative. Neither the failure nor any delay by any party in exercising any right, power, or privilege under this Agreement will operate as a waiver
of such right, power, or privilege, and no single or partial exercise of any such right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or the exercise of any other right, power, or privilege.

 Section 9.6 Binding Effect; Delegation of Duties Prohibited. This Agreement shall inure to the benefit of, and shall be
binding upon, the parties hereto and their respective successors, assigns, heirs, and legal representatives, including any entity with which the Employer may merge or consolidate or to which all or substantially all of its assets may be transferred.
The duties and covenants of the Employee under this Agreement, being personal, may not be delegated. 
 Section 9.7 Notices.
All notices, consents, waivers, and other communications under this Agreement must be in writing and will be deemed to have been duly given when (a) delivered by hand (with written confirmation of receipt), (b) sent by telecopier (with
written confirmation of receipt), provided that a copy is mailed by registered mail, return receipt requested, or (c) when received by the addressee, if sent by a nationally recognized overnight delivery service (receipt requested), in each
case to the appropriate addresses and telecopier numbers set forth below (or to such other addresses and telecopier numbers as a party may designate by notice to the other parties): 
  

					
	 If to the Employer:
	 		  	 Endo Pharmaceuticals Holdings Inc.

		 		  	 100 Endo Boulevard
 Chadds Ford, PA 19317

		 		  	 Attention: Peter A. Lankau

			
	 If to the Employee:
	 		  	 Charles A. Rowland, Jr.

		 		  	 100 Endo Boulevard
 Chadds Ford, PA 19317

			
		 		  	 and the Employee’s most recent home
 address on file with the Employer.


  

 -11- 








 Section 9.8 Entire Agreement; Amendments. This Agreement contains the entire agreement
between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written, between the parties hereto with respect to the subject matter hereof. This Agreement may not be amended orally,
but only by an agreement in writing signed by the parties hereto. 
 Section 9.9 Governing Law. This Agreement will be governed
by and construed under the laws of the State of Delaware without regard to conflicts of laws principles. The parties hereto agree that, in any legal suit, action or proceeding brought by a party hereto arising out of or based upon this Agreement,
the losing party shall pay to the prevailing party the reasonable attorneys’ fees and expenses incurred by the prevailing party in addition to the award or judgment sum determined due and payable by the losing party, if any, in such action.

 Section 9.10 Section Headings, Construction. The headings of Sections in this Agreement are provided for convenience only
and will not affect its construction or interpretation. All references to “Section” or “Sections” refer to the corresponding Section or Sections of this Agreement unless otherwise specified. All words used in this Agreement will
be construed to be of such gender or number as the circumstances require. Unless otherwise expressly provided, the word “including” does not limit the preceding words or terms. 
 Section 9.11 Severability. If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the
other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 Section 9.12 Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an
original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement. 
 [SIGNATURES
FOLLOW] 
  

 -12- 








 IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written
above. 
  

			
	ENDO PHARMACEUTICALS HOLDINGS INC.
		
	By:	 	 /s/ PETER A. LANKAU

	Name:	 	Peter A. Lankau
	Title:	 	President and Chief Executive Officer
	
	 /s/ CHARLES A. ROWLAND, JR.

	Charles A. Rowland, Jr.


  

 -13- 








 Exhibit A 
 Duties 
 You will be a partner to the CEO and the senior management team in the development of the company’s
strategic plans and the creation of future value. Although your primary responsibilities will be the financial elements of the organization, your general business acumen, leadership, business judgment, and management experience will be equally
important in impacting the organization in a meaningful way. You will inform the thinking around decisions involving the company’s overall strategies, plans, and operations as well as assure that the company maintains the strong financial
infrastructure required to support continued growth. Specific responsibilities will include but will not be limited to: 
 Senior
Leadership – Business judgment and experience regarding commercial operations, business/corporate development, clinical development and human capital and infrastructure/systems development, amongst others, will be expected competencies.

 Operations/Accounting – In the context of a continually evolving and complex operating structure, you will be responsible for
the implementation and management of the accounting structure, methods, systems, operating procedures and FASB, Sarbanes-Oxley and SEC requirements. 
 Strategic and Financial Planning/Forecasting – Management of corporate-wide financial planning, analysis, procedures, measures, budgeting and forecasting, project specific financial analysis and general risk analysis.

 Reporting and Analysis – Responsible for the timely and accurate reporting and analysis, both written and oral, of financial
and associated business information to internal, external, and regulatory constituencies. 
 Finance – The evaluation, analysis
and execution of all capital raising and all other finance related projects. 
 Corporate and Business Development – Responsible
for interfacing with corporate and business development in the analysis, execution and integration of mergers, acquisitions, business partnerships, client relationships, licensing agreements, etc. 
 Investor Relations - Working closely with the CEO and additional senior management as appropriate, leading the effort to interface with the
investment community, specifically in working with institutional investors, research analysts, investment bankers and corporate partners. 
  

 -14-